Blue Water Vaccines, Inc.
Blue Water Vaccines, Inc. (BWV) Stock Overview
Explore Blue Water Vaccines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Company Profile
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Dr. Neil J. Campbell MA, MBA
12
201 East Fifth Street, Cincinnati, OH
2022